{"a":[{"_":"Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market","$":{"href":"/biotech/eli-lilly-inks-28b-ataibeckley-buyout-challenge-jj-psychedelic-mental-health-market","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Eli Lilly announced the acquisition of AtaiBeckley for $2.8 billion upfront to expand its presence in the psychedelic mental health market, competing with Johnson & Johnson and others in this emerging therapeutic area.
Importance:8/10
Sentiment:
0.60
M&Apsychedelicmental healthEli LillyAtaiBeckleyacquisition
Related Companies
Read the original article
Published by FierceBiotech on July 16, 2026 7:33 AM